Moreover, bone marrow stromal cell antigen 2 (BST2) expression in microglia cells was significantly increased during the pre-symptomatic stage and further exacerbated after the disease onset, implying that BST2 is a key mediator and potential candidate target for ALS diagnosis and therapy. Here, BST2 is linked to amyotrophic lateral sclerosis.